Loading




0Years Experience
About Our CompanyAbout Our CompanyAbout Our Company

We are Partner of Your Healthness

Parham Gostar Fars Research Center is a private company with a history of more than twenty-five years of activity in the field of laboratory and scientific research in Iran and is responsible for the management of many innovations and technologies in various fields. The PKM team, a subsidiary of Parham Research Center, is trying to enter a small but important product in order to protect public health and healthcare systems from escalating global prevalence of unexpected microbial infestations, (SARS, SARS-CoV-2, and COVID-19,….). PkM team has presented its idea in the field of Antimicrobial textile production following of COVID-19 at 2021. The competitive factor of our product is related to the invention of the fabric layer that coated with some novel biodegradable and biocompatible antimicrobial agents (nanoparticles, etc.). The Nano Anti Pathogen Mask project was the first project of the production team. Now that the pandemic has subsided and the demand for masks has decreased, the team plans to commercialize the antimicrobial Solutions in a wider field including medical supplies(Mask ,gowns,….), clothing, bedding, towels and upholstery, all infused with advanced antimicrobial properties. The recent research have been reveled that the demand for medical textile applications globally is booming with increasing demand for maintaining high standards of hygiene and a bacteria-free environment and this will drive the growth of the market. For instance, as per the report by the Centers for Disease Control and Prevention (CDC), approximately 1 in 31 hospital patients has at least one healthcare-associated infection in the US and this is driving the demand for more antimicrobial protective clothing. Additionally, , the demand for apparel applications is expanding globally owing to the increasing awareness about skin infections caused because of low-grade fabrics and this will drive the growth of the market in the forecast period. In this field, the global Antimicrobial Textiles market size was valued at USD 10914.66 million in 2022 and is expected to expand at a CAGR of 7.28% during the forecast period, reaching USD 16635.41 million by 2028. The solutions global market is estimated to be USD 4250 million in 2022 and projected to reach to USD 8000 million by 2030. Market growth will average 9.46% from 2022 to 2030.(Feb 12,2024) Therefore, considering the wide range of benefits of antimicrobial solutions, from protecting public health to improving product performance and sustainability, we have devised an effective and versatile antimicrobial textile solution. Our business is planning to aim Canada firstly and Global market till 2th year.( Due to the Canadian government's delay in processing immigration and work visa, considering the product's entry into the production stage, the team 8 decided to industrialize and commercialize in the Iranian market and, if successful, to obtain the global necessary permits, to enter the markets of regional countries. Mission, vision, values • Every human has the right to live free of pathogens anywhere in the world, and PKM aims to build a world free of the threat of infectious diseases and commits itself to products that have the least possible environmental pollution. PKM will always strive to be respectful of friends and to offer the best offer to all customers around the world by observing professional ethics. • PKM will strive to make its product available to the public in the best and cheapest conditions and also intends to be among the top 3 companies in the Canada in the field of pathogen control solutions in the next 20 years and will try to achieve this position. Over the years, PKM will offer a basket of different complementary products with the support of the best inventors and researchers.

  • Pathogen Killer Mask” not only traps the pathogens but also kills them.
  •  Competitive advantages are highly efficient in trapping pathogens as well as the capability of destroying pathogenic particles such as viral, bacterial and fungal pathogens.
About Our CompanyAbout OurCompanyAbout OurCompany

We Have Some Innovative Health Solution & Services

90%
MVP
100%
PILOT
70%
LAUNCH
We are ready to
assist you
Our MemebersOur MemebersOur Memebers

Meet Our Expert Team
Member

Description of the management team

Dr. Iman Sadeghpour

Team Manager, CEO and Market manager

Mrs. Sedigheh Montaseri

Project controller and researcher and clinical approval

Dr. Effat Nikfarjamshirazi

Chief Technical Officer (CTO)

Mr.Ahmad Sadeghpour

Procurement and Tools supplier and tools maker

Mr .Emad Sadeghpour

R&D, Raw material producer

Our Office Time

Know Our Location

Do you have any question?